Frido K Brühl

8PUBLICATIONS
17CO-AUTHORS
Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Haematological tumoursMetabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 24, 2026
CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

Stefan Forster, Chantal Reinhardt, Maxime Boy

|Jan 04, 2024
The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory.

Frido K Bruehl, Mazen M Osman, Dong Chen

|Jan 04, 2024
"Quadruple-hit" primary testicular diffuse large B-cell lymphoma with MYD88 L265P mutation, IGH::MYC, and IRF4- and BCL6-rearrangements.

Frido K Bruehl, Rhett P Ketterling, Lisa M Rimsza

|Oct 20, 2021
A comprehensive analysis of cytopenias and bone marrow morphology in patients with a history of bariatric and metabolic surgery.

Frido K Bruehl, David S Bosler, W Scott Butsch

|Mar 02, 2021
Does histological assessment accurately distinguish separate primary lung adenocarcinomas from intrapulmonary metastases? A study of paired resected lung nodules in 32 patients using a routine next-generation sequencing panel for driver mutations.

Frido K Bruehl, Erika E Doxtader, Yu-Wei Cheng

|Aug 14, 2020
Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcomas of the Spleen Are EBV-Associated and Lack Other Commonly Identifiable Molecular Alterations.

Frido K Bruehl, Elizabeth Azzato, Lisa Durkin

Pageof 2

Frequent Collaborators

1 joint publications

C Astbury

1 joint publications

C D Sturgis

1 joint publications

Sanjay Mukhopadhyay

1 joint publications

Sarah L Ondrejka